Nisa Investment Advisors’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
Other funds holding OLMA
PBA
BCLSI
BI
SL
CAM
LGM
Nisa Investment Advisors's OLMA Position: Q1 2026 in Review
Nisa Investment Advisors increased its Olema Pharmaceuticals (OLMA) stake by 56% in Q1 2026, buying an estimated $46.7K and bringing the position to 5,864 shares worth $87.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.
Nisa Investment Advisors first reported a position in OLMA in Q1 2022 and has held it in 10 quarters since. The position peaked at $134K in Q1 2022. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.
- Nisa Investment Advisors held 5,864 shares of Olema Pharmaceuticals worth $87.4K as of Q1 2026.
- Nisa Investment Advisors bought 2,100 Olema Pharmaceuticals shares in Q1 2026, an estimated $46.7K.
- Olema Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1474 holding.
- Nisa Investment Advisors first reported a position in Olema Pharmaceuticals in Q1 2022 and has held it in 10 quarters since.
- Nisa Investment Advisors's Olema Pharmaceuticals position peaked at $134K in Q1 2022.
- 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.